- Home
- KRMD vs BGX Comparison
KRMD vs BGX Comparison
Compare KRMD & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- BGX
- Stock Information
- Founded
- KRMD 1980
- BGX 2010
- Country
- KRMD United States
- BGX United States
- Employees
- KRMD N/A
- BGX N/A
- Industry
- KRMD Medical/Dental Instruments
- BGX Trusts Except Educational Religious and Charitable
- Sector
- KRMD Health Care
- BGX Finance
- Exchange
- KRMD Nasdaq
- BGX Nasdaq
- Market Cap
- KRMD 182.0M
- BGX 161.1M
- IPO Year
- KRMD N/A
- BGX N/A
- Fundamental
- Price
- KRMD $4.09
- BGX $12.67
- Analyst Decision
- KRMD Strong Buy
- BGX
- Analyst Count
- KRMD 5
- BGX 0
- Target Price
- KRMD $4.50
- BGX N/A
- AVG Volume (30 Days)
- KRMD 108.2K
- BGX 67.9K
- Earning Date
- KRMD 03-12-2025
- BGX 01-01-0001
- Dividend Yield
- KRMD N/A
- BGX 10.34%
- EPS Growth
- KRMD N/A
- BGX N/A
- EPS
- KRMD N/A
- BGX N/A
- Revenue
- KRMD $31,993,796.00
- BGX N/A
- Revenue This Year
- KRMD $17.79
- BGX N/A
- Revenue Next Year
- KRMD $15.73
- BGX N/A
- P/E Ratio
- KRMD N/A
- BGX N/A
- Revenue Growth
- KRMD 11.57
- BGX N/A
- 52 Week Low
- KRMD $1.98
- BGX $10.69
- 52 Week High
- KRMD $4.60
- BGX $12.44
- Technical
- Relative Strength Index (RSI)
- KRMD 58.06
- BGX 45.82
- Support Level
- KRMD $3.81
- BGX $12.61
- Resistance Level
- KRMD $4.19
- BGX $12.78
- Average True Range (ATR)
- KRMD 0.20
- BGX 0.17
- MACD
- KRMD -0.01
- BGX 0.01
- Stochastic Oscillator
- KRMD 61.91
- BGX 52.27
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About BGX Blackstone Long Short Credit Income Fund
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategy in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first- and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.